Qube Research & Technologies (QRT)
MIST icon

Qube Research & Technologies (QRT)’s Milestone Pharmaceuticals MIST Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-34,596
Closed -$69.9K – 3894
2025
Q4 		$69.9K Buy
+34,596
New +$74.5K ﹤0.01% 3247
2024
Q3 		– Sell
-194
Closed -$258 – 3807
2024
Q2 		$258 Hold
194
– – ﹤0.01% 3371
2024
Q1 		$347 Hold
194
– – ﹤0.01% 4109
2023
Q4 		$324 Hold
194
– – ﹤0.01% 3953
2023
Q3 		$601 Buy
+194
New +$603 ﹤0.01% 3664

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MIST Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Milestone Pharmaceuticals (MIST) in Q1 2026, closing a stake of 34,596 shares — an estimated $69.9K sold.

Qube Research & Technologies (QRT) first reported a position in MIST in Q3 2023 and held it in 5 quarters. The position peaked at $69.9K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Milestone Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 34,596 Milestone Pharmaceuticals shares in Q1 2026, an estimated $69.9K.
  • Qube Research & Technologies (QRT) first reported a position in Milestone Pharmaceuticals in Q3 2023 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Milestone Pharmaceuticals position peaked at $69.9K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.